MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    DTI in Parkinson’s disease: Asymmetric progression

    L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)

    Objective: To study the rate of change of brain region diffusion tensor imaging (DTI) parameters between the right and left sides in PD patients using…
  • 2016 International Congress

    Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes

    J.R. Isaacson, N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)

    Objective: To assess changes in clinical diagnosis and/or treatment of 200 consecutive patients with clinically uncertain Parkinsonian syndromes who underwent DaTscan imaging with ioflupane for…
  • 2016 International Congress

    Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview

    R. Ando, C. Yamazaki, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, K. Nakashima, M. Nomoto, Safe Driving Study Group of Japan (Tohon, Japan)

    Objective: We investigated the vehicle driving situation, clinical signs and symptoms of PD patients to obtain the information for safe driving. Background: PD neurologists are…
  • 2016 International Congress

    Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients

    M.M. Mielke, C.E. Hagen, R. Savica, J.A. Syrjanen, X.M.T. Persson, C. Schulte, R. Dodel, M. Balzer-Geldsetzer, J.B. Schulz, K. Reetz, U. Wullner, A. Spottke, A. Storch, H.U. Wittchen, O. Riedel, E. Kalbe, S. Graber-Sultan, T. Gasser, D. Berg, I. Liepelt-Scarfone (Rochester, MN, USA)

    Objective: To determine whether plasma ceramides, glucosylceramides, and their ratios predict cognitive decline among cognitively normal Parkinson's disease (PD) patients. Background: There are no biomarkers…
  • 2016 International Congress

    Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

    E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

    Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…
  • 2016 International Congress

    Is Apple Watch a new hope for patients with Parkinson’s disease?

    H. Ohtsubo, H. Iwaki, R. Andou, T. Tsujii, H. Babe, N. Nishikawa, M. Nagai, M. Nomoto (Tohon, Japan)

    Objective: To assess the capability of the smart watch (Apple Watch®) as a simple monitoring tool of motor fluctuation in patients with Parkinson's disease (PD).…
  • 2016 International Congress

    Balance in patients with newly diagnosed Parkinson´s disease – A three year follow-up of a cohort in Northern Sweden

    C. Johansson, E. Johansson, G.M. Johansson, B. Lindström, L. Forsgren (Sävar, Sweden)

    Objective: The aim of this study was to examine balance, subjective experienced unsteadiness and self-reported falls among patients with idiopathic Parkinson´s Disease, at the very…
  • 2016 International Congress

    Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)

    H. Yasar, M.G. Senol, S. Tasdemir, U.H. Ulas, S. Alay (Ankara, Turkey)

    Objective: The aim of this study was to evaluate the validity and reliability of the Turkish version of the SCOPA-AUT. Background: The scales for outcomes…
  • 2016 International Congress

    Sarcopenia and dynapenia in patients with parkinsonism

    E. Cassani, E. Cereda, G. Pinelli, L. Iorio, A. Valentino, C. Pusani, V. Ferri, C. Bolliri, M. Pasqua, G. Frazzitta, M. Barichella, G. Pezzoli (Milano, Italy)

    Objective: The aims of the present study were to estimate prevalence of sarcopenia and dynapenia in patients with Parkinsonian syndromes and to investigate their association…
  • 2016 International Congress

    How accurate is the prediction of driving ability in a Parkinson’s clinic setting?

    C. Thomas, R. Amin, B. Mohamed (Cardiff, United Kingdom)

    Objective: To determine whether routine clinical assessment (motor examination, cognitive assessment and global clinical impression) accurately predicts the ability of People with Parkinson's (PwP) to…
  • « Previous Page
  • 1
  • …
  • 353
  • 354
  • 355
  • 356
  • 357
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley